North America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)
The North America neurotoxins market is expected to grow from US$ 4,801.29 million in 2023 to US$ 8,416.95 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2023 to 2028.
Emergence of Innovative Facial Aesthetic Products Fuels North America Neurotoxins Market
The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"—a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins. Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus. Therefore, emergence of innovative facial aesthetic products helps the North America neurotoxin market to grow.
North America Neurotoxins Market Overview
The North America neurotoxin market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for neurotoxins. The market growth in the region is attributed to the increasing product launches, growing FDA approvals for neurotoxins for various muscular conditions, rising aging population, increasing numbers of non-surgical or minimally invasive cosmetic procedures, increasing number of aesthetic procedures, and growing demand for minimally invasive therapeutics.
North America Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)
North America Neurotoxins Market Segmentation
The North America neurotoxins market is segmented into product type, application, end user, and country. Based on product type, the North America neurotoxins market is sub segmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.
Based on application, the North America neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.
Based on end user, the North America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.
Based on country, the North America neurotoxins market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.
AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, Merz Pharma GmbH & Co KGaA, Metabiologics, and Revance Therapeutics Inc are among the leading companies operating in the North America neurotoxins market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Neurotoxin Market – by Type
1.3.2 North America Neurotoxin Market – by Application
1.3.3 North America Neurotoxin Market – by End User
1.3.4 North America Neurotoxin Market – by Country
2. North America Neurotoxin Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Neurotoxin Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Neurotoxin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surge in Cosmetic Procedures to Improve Appearance
5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
5.2.1 Improper/Inappropriate Injection Technique
5.3 Market Opportunities
5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
5.4 Future Trends
5.4.1 BOTA for Assisted Reproductive Technology (ART)
5.5 Impact Analysis
6. North America Neurotoxin Market
6.1 North America Neurotoxin Market Revenue Forecast and Analysis
7. North America Neurotoxin Market – Revenue and Forecast to 2028 – By Type
7.1 Overview
7.2 North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
7.3.1 Overview
7.3.2 Botox: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
7.4.1 Overview
7.4.2 Dysport: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
7.5.1 Overview
7.5.2 Xeomin: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Neurotoxin Market – Revenue and Forecast to 2028 – By Application
8.1 Overview
8.2 North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
8.3.1 Overview
8.3.2 Therapeutic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Neurotoxin Market – Revenue and Forecast to 2028 – By End User
9.1 Overview
9.2 North America Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
9.4.1 Overview
9.4.2 Medical Spas and Beauty Centers: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
9.5.1 Overview
9.5.2 Dermatology Clinics: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Neurotoxin Market –Revenue and Forecast to 2028- Country Analysis
10.1 Overview
10.1.1 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
10.1.1.1 US: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 Canada: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 Mexico: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
11. North America Neurotoxins Market–Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merz Pharma GmbH & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AbbVie Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Revance Therapeutics Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Ipsen SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Medytox Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Hugel Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Metabiologics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Organic Growth Strategies in Neurotoxins Market
Table 12. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Neurotoxin Market Segmentation
Figure 2. North America Neurotoxin Market by Country
Figure 3. North America Neurotoxin Market Overview
Figure 4. North America Neurotoxin Market, By Type
Figure 5. North America Neurotoxin Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. North America Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 8. North America Neurotoxin Market – Revenue Forecast and Analysis – 2021–2028
Figure 9. North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 10. Botox: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Dysport: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Xeomin: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 15. Therapeutic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Aesthetic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 18. Hospitals: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Medical Spas and Beauty Centers: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermatology Clinics: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America: Neurotoxin Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 24. US: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Canada: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Mexico: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
- AbbVie Inc
- Hugel Inc
- Ipsen SA
- Medytox Inc
- Merz Pharma GmbH & Co KGaA
- Metabiologics
- Revance Therapeutics Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America neurotoxins market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution